Atlas Trials

A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)

Clinical trial NCT04020341 · COMPLETED

Trial details

NCT number
NCT04020341
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Urinary Tract Infections
Start date
2019-10-17
Primary completion
2022-11-30
Enrollment
1531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.